VP
HRMY icon

venBio Partners’s Harmony Biosciences HRMY Stock Holding History

venBio Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Sell
472,194
-17,000
-3% -$536K 3.31% 6
2026
Q1 		$13.7M Hold
489,194
– – 4.88% 4
2025
Q4 		$18.3M Hold
489,194
– – 8.46% 3
2025
Q3 		$13.5M Hold
489,194
– – 7.64% 4
2025
Q2 		$15.5M Hold
489,194
– – 13.47% 2
2025
Q1 		$16.2M Sell
489,194
-50,000
-9% -$1.79M 13.14% 3
2024
Q4 		$18.6M Sell
539,194
-75,400
-12% -$2.59M 10.87% 3
2024
Q3 		$24.6M Sell
614,594
-420,802
-41% -$14.8M 12.65% 3
2024
Q2 		$31.2M Hold
1,035,396
– – 13.49% 4
2024
Q1 		$34.8M Hold
1,035,396
– – 12.33% 3
2023
Q4 		$33.4M Hold
1,035,396
– – 5.01% 4
2023
Q3 		$33.9M Hold
1,035,396
– – 9.62% 5
2023
Q2 		$36.4M Hold
1,035,396
– – 13.19% 4
2023
Q1 		$33.8M Hold
1,035,396
– – 18.74% 3
2022
Q4 		$57.1M Sell
1,035,396
-90,277
-8% -$4.96M 17.69% 3
2022
Q3 		$49.9M Sell
1,125,673
-323,047
-22% -$15.8M 11.53% 4
2022
Q2 		$70.7M Sell
1,448,720
-95,764
-6% -$4.31M 20.12% 2
2022
Q1 		$75.1M Sell
1,544,484
-1,195,927
-44% -$48.8M 16.66% 2
2021
Q4 		$117M Sell
2,740,411
-322,783
-11% -$12.9M 21.05% 2
2021
Q3 		$117M Sell
3,063,194
-441,430
-13% -$14.2M 11.7% 2
2021
Q2 		$98.9M Hold
3,504,624
– – 11.68% 2
2021
Q1 		$116M Hold
3,504,624
– – 11% 2
2020
Q4 		$127M Hold
3,504,624
– – 11.18% 2
2020
Q3 		$119M Buy
+3,504,624
New +$128M 18.06% 2

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

venBio Partners's HRMY Position: Q2 2026 in Review

venBio Partners reduced its Harmony Biosciences (HRMY) stake by 3.5% in Q2 2026, selling an estimated $536K and leaving 472,194 shares worth $17.2M. The position accounts for 3.31% of the portfolio, ranked #6.

venBio Partners first reported a position in HRMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $127M in Q4 2020. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • venBio Partners held 472,194 shares of Harmony Biosciences worth $17.2M as of Q2 2026.
  • venBio Partners sold 17,000 Harmony Biosciences shares in Q2 2026, an estimated $536K.
  • Harmony Biosciences made up 3.31% of venBio Partners's portfolio in Q2 2026, its #6 holding.
  • venBio Partners first reported a position in Harmony Biosciences in Q3 2020 and has held it in 24 quarters since.
  • venBio Partners's Harmony Biosciences position peaked at $127M in Q4 2020.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on venBio Partners's 13F filing for Q2 2026, filed 14 Aug 2026.